CORONA Remedies Ltd
NSE: CORONA | BSE: 544644
₹2,041.10
₹2.80
(0.14%)
As on 07-Oct-2026IST
Market cap
₹12,478 Cr
Revenue (TTM)
₹1,479 Cr
P/E Ratio
62.7
P/B Ratio
15.5
Div. Yield
0.5 %
Quality Score
8/10
Growth Score
8/10
Valuation Score
2/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹199 Cr
-
ROE
27.4 %
-
ROCE
31.7 %
-
Industry P/E
32.19
-
EV/EBITDA
38.3
-
Debt to Equity
0.2
-
Book Value
₹131.9
-
EPS
₹34.9
-
Face value
10
-
Shares outstanding
61,160,088
6 Years Aggregate
CFO
₹622.78 Cr
EBITDA
₹939.34 Cr
Net Profit
₹579.53 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
CORONA Remedies
| 47.4 | -2.8 | 1.8 | -- | -- | -- | -- |
|
BSE Healthcare
| 14.5 | -2.3 | -0.7 | 13.1 | 21.0 | 13.8 | 11.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
CORONA Remedies
|
2,041.1 | 12,477.9 | 1,479.1 | 198.6 | 18.6 | 30.3 | 62.7 | 15.5 |
| 5,918.0 | 14,797.5 | 2,432.1 | 169.6 | 8.7 | 20.8 | 87.2 | 16.4 | |
| 681.6 | 7,241.1 | 1,005.2 | 141.7 | 15.1 | 11.8 | 53.2 | 5.9 | |
| 2,649.1 | 20,067.1 | 2,287.3 | 678.1 | 31.4 | 19.7 | 30.2 | 5.5 | |
| 1,145.8 | 15,960.5 | 3,229.7 | 666.9 | 26.6 | 18.8 | 24.8 | 4.0 | |
| 3,815.1 | 17,429.9 | 2,569.8 | 735.2 | 34.4 | 19.2 | 23.7 | 4.0 | |
| 5,234.0 | 8,679.5 | 1,432.9 | 356.9 | 30.8 | 58.2 | 24.3 | 14.1 | |
| 1,071.2 | 20,991.8 | 1,682.5 | 273.5 | 21.0 | 11.1 | 70.6 | 7.8 | |
| 1,100.6 | 10,165.3 | 5,004.4 | 635.3 | 14.5 | 19.8 | 16.6 | 3.1 | |
| 889.3 | 7,169.4 | 872.6 | 198.4 | 29.7 | 17.4 | 36.1 | 5.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
About CORONA Remedies
--
-
Incorporated
2004
-
Chairman
Kirti Mehta
-
Managing Director
Nirav Mehta
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about CORONA Remedies Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for CORONA Remedies
What is the current share price of CORONA Remedies Ltd Today?
The share price of CORONA Remedies Ltd is ₹2,041.10 (NSE) and ₹2,039.85 (BSE) as of 07-Oct-2026 IST. CORONA Remedies Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of CORONA Remedies Ltd?
The P/E ratio of CORONA Remedies Ltd is 62.69 times as on 07-Oct-2026, a 95 premium to its peers’ median range of 32.19 times.
The P/B ratio of CORONA Remedies Ltd is 15.46 times as on 07-Oct-2026, a 211 premium to its peers’ median range of 4.97 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
51.41 |
12.74 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
What is the 52 Week High and Low of CORONA Remedies Ltd?
The 52-week high and low of CORONA Remedies Ltd are Rs 2,292.40 and Rs 1,336.60 as of 07-Oct-2026.
What is the market cap of CORONA Remedies Ltd?
CORONA Remedies Ltd has a market capitalisation of ₹ 12,478 Cr as on 07-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in CORONA Remedies Ltd?
Before investing in CORONA Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.